会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption
    • 用于软性隐形眼镜的眼用组合物,增强软性隐形眼镜的润湿性的方法以及抑制萜类吸附的方法
    • US06545058B2
    • 2003-04-08
    • US09486212
    • 2000-02-24
    • Koji DoiHisayuki NakayamaTakuya NakajimaNoriko Sakai
    • Koji DoiHisayuki NakayamaTakuya NakajimaNoriko Sakai
    • A61K31045
    • A61K31/125A61K9/0048A61K31/045Y10S514/912
    • The present invention provides an ophthalmic composition for soft contact lenses (SCL), which contains a terpenoid as an active ingredient, an ophthalmic composition for SCL, which contains polyoxyethylene sorbitan ester, a method of enhancing the wettability of soft contact lenses, which comprises bringing terpenoid into contact with SCL and a method of inhibiting adsorption of terpenoid onto SCL, which comprises adding polyoxyethylene sorbitan ester to an ophthalmic composition containing a terpenoid. The ophthalmic composition containing a terpenoid improves, for example, the wettability of SCL, thereby to inhibit decrease in the water content of SCL. As a result, it can inhibit a dry feeling and an uncomfortable feeling during wearing SCL and is useful for enhancing the wettability of SCL. Further, addition of polyoxyethylene sorbitan ester leads to the inhibition of adsorption of terpenoid onto SCL.
    • 本发明提供一种含有萜类化合物作为活性成分的软性隐形眼镜(SCL)用眼用组合物,含有聚氧乙烯山梨聚糖酯的SCL用眼用组合物,增强软性隐形眼镜的润湿性的方法, 萜类化合物与SCL接触以及抑制萜类化合物在SCL上吸附的方法,其包括将聚氧乙烯失水山梨醇酯加入到含有萜类化合物的眼用组合物中。 包含萜类化合物的眼用组合物可改善例如SCL的润湿性,从而抑制SCL的水分含量降低。 结果,可以抑制穿着SCL时的干燥感和不适感,并且对于提高SCL的润湿性是有用的。 此外,加入聚氧乙烯脱水山梨糖醇酯导致抑制萜类化合物在SCL上的吸附。
    • 4. 发明授权
    • Stabilized powder formulations
    • 稳定粉末配方
    • US06369115B1
    • 2002-04-09
    • US09528519
    • 2000-03-20
    • Gary Ward
    • Gary Ward
    • A61K31045
    • A61K9/0075A61K31/167A61K31/56Y10S514/826Y10S514/951Y10S514/97A61K2300/00
    • A dry powder formulation for treatment of pulmonary conditions, via inhalation, includes an effective amount of formoterol or a salt or solvate thereof, in a dry powder form, an effective amount of fluticasone, in a dry powder form, and an excipient. A method for preparing a physically stable dry powder formulation for inhalation includes the steps of micronizing a first active polar drug, a second active non-polar drug, and a polar excipient. The second non-polar active drug is first blended with the excipient to form an intermediate mixture. The intermediate mixture is then blended with the first active polar drug. The increased separation of the polar drug and polar excipient stabilizes the formulation.
    • 用于通过吸入治疗肺部病症的干粉制剂包括有效量的福莫特罗或其盐或溶剂合物,干粉形式,有效量的氟替卡松,干粉形式和赋形剂。 制备用于吸入的物理稳定的干粉制剂的方法包括使第一活性极性药物,第二活性非极性药物和极性赋形剂微粉化的步骤。 首先将第二种非极性活性药物与赋形剂混合以形成中间体混合物。 然后将中间体混合物与第一活性极性药物混合。 极性药物和极性赋形剂的分离增加使制剂稳定。
    • 6. 发明授权
    • Method of treating rosacea
    • 治疗酒渣鼻的方法
    • US06723755B2
    • 2004-04-20
    • US10430917
    • 2003-05-07
    • Piotr Chomczynski
    • Piotr Chomczynski
    • A61K31045
    • A61K31/047A61K31/045
    • A method for topically treating rosacea is disclosed. In this method, an active material having the formula given below is applied to the patient at the site of said rosacea: wherein R1 is selected from —OH and C1-C3 alkyl OH; and R2, R3, R4, R5 and R6 are independently selected from —H, —OH, C1-C6 alkyl, and C3-C6 cycloalkyl. Preferred active materials include 1,2-cyclohexanediol, 1,3-cyclohexanediol, 1,4-cyclohexanediol, and mixtures of those materials. Methods for treating acne vulgaris, as well as colds, flu, sinusitis, and ear infections, using these actives are also disclosed.
    • 公开了一种局部治疗酒渣鼻的方法。 在该方法中,在所述红斑痤疮的部位将具有下式的活性物质施用于患者:其中R 1选自-OH和C 1 -C 3烷基OH; R 2,R 3,R 4,R 5和R 6独立地选自-H,-OH,C 1 -C 6烷基和C 3 -C 6环烷基。 优选的活性物质包括1,2-环己二醇,1,3-环己二醇,1,4-环己二醇以及这些物质的混合物。 还公开了使用这些活性物质治疗寻常型痤疮以及感冒,流感,鼻窦炎和耳朵感染的方法。